Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.6K
T Cell Types and Functions01:24

T Cell Types and Functions

2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same author

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same author

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026
Same author

Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survival.

Cancer discovery·2026
Same author

Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.

Cancer research·2026
Same journal

Enhancement of ferroptosis in escape variant tumor cells by IFN-γ derived from antigen-specific T cells controls tumor with heterogeneity.

Cancer immunology research·2026
Same journal

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

Cancer immunology research·2026
Same journal

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

Cancer immunology research·2026
Same journal

VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer.

Cancer immunology research·2026
Same journal

A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors.

Cancer immunology research·2026
Same journal

Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.

Cancer immunology research·2026
查看所有相关文章

相关实验视频

Updated: Jan 13, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.4K

抑制IL-10R会诱导中性粒细胞的瘤杀伤活性.

Danny N Khalil1, Ricardo Gomez2, Amit Regev2

  • 1Memorial Sloan Kettering Cancer Center New York, NY United States.

Cancer immunology research
|January 7, 2026
PubMed
概括
此摘要是机器生成的。

中性粒细胞可以通过脱粒化直接杀死瘤细胞,独立于T细胞. 这条由抗CD40疗法和G-CSF增强的途径在癌症治疗中显示出前景.

更多相关视频

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.4K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.3K

相关实验视频

Last Updated: Jan 13, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.4K
Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.4K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.3K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 在瘤学瘤学.

背景情况:

  • 已知中性粒细胞在抗瘤免疫中的作用,但直接杀死瘤细胞的理解较少.
  • 研究中性粒细胞对瘤细胞的直接细胞毒性作用对于新型癌症疗法至关重要.

研究的目的:

  • 为了确定中性粒细胞是否可以直接杀死瘤细胞,而不依赖于T细胞的反应.
  • 阐明中性粒细胞介导的瘤细胞杀伤的机制和治疗潜力.

主要方法:

  • 使用显微镜,单细胞检测和功能检测来观察中性粒细胞与瘤细胞的相互作用.
  • 使用了临床前模型和涉及抗CD40治疗的1/1b/2期临床试验.
  • 在患者中分析细胞因子水平 (IL-12,IFNγ,IL-10) 和中性粒细胞扩张 (G-CSF).

主要成果:

  • 与IL-10受体阻断相结合的抗CD40疗法诱导了IL-12和IFNγ分泌,导致型中性粒细胞活性.
  • 中性粒细胞介导的瘤细胞杀伤需要身体接触和脱粒化,其特点是侵入性表型.
  • 临床试验显示,抗CD40治疗后IL-12,IFNγ和IL-10的增加;较低的IL-10与更好的生存相关.
  • 在接受抗CD40治疗的患者中,G-CSF诱导的中性粒细胞扩张改善了生存率.

结论:

  • 中性粒细胞具有直接的瘤解毒能力,通过特定的治疗途径激活.
  • 这种中性粒细胞介导的杀死机制是晚期癌症的潜在治疗点.
  • 将抗CD40疗法与G-CSF结合使用可能会提高癌症患者的生存结果.